References
- AjaniJATakiuchiHRecent developments in oral chemotherapy options for gastric carcinomaDrugs199958Suppl 3859010711846
- FengSSDongYPoly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugsBiomaterials2005266068607615894372
- ArangoaMAPonchelGOrecchioniAMRenedoMJDucheneDIracheJMBioadhesive potential of gliadin nanoparticulate systemsEur J Pharm Sci20001133334111033077
- ArechabalaBCoiffardCRivallandPCoiffardLJMde Roeck-HoltzhauerYComparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH releaseJ Appl Toxicol19991916316510362266
- AtyabiFAghaei MoghaddamFDinarvandRZohuriaan-MehrMJPonchelGThiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: synthesis and characterizationCarbohydr Polym2008745967
- Bernkop-SchnürchAKastCEChemically modified chitosans as enzyme inhibitorsAdv Drug Deliv Rev20015212713711718936
- MangatalLAdelineMTGuénardDGuéritte-VoegeleinFPotierPApplication of the vicinal oxymination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron19894541774190
- KellandLRAbelGComparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell linesCancer Chemother Pharmacol1992304444501356649
- EiermannWDocetaxel – maximising outcomes towards cure in early breast cancerBreast200615Suppl 3S1316
- EscobarPFRosePGDocetaxel in ovarian cancerExpert Opin Pharmacother20056152719272616316310
- Iwao-KoizumiKMatobaRUenoNPrediction of docetaxel response in human breast cancer by gene expression profilingJ Clin Oncol200523342243115659489
- Van ZuylenLVerweijJSparreboomARole of formulation vehicles in taxane pharmacologyInvest New Drugs200119212514111392447
- ShouMMartinetMKorzekwaKRKrauszKWGonzalezFJGelboinHVRole of human cytochrome P450 3 A4 and 3 A5 in the metabolism of taxotere and its derivatives: enzyme specificity, inter-individual distribution and metabolic contribution in human liverPharmacogenetics1998853914019825831
- MalingreMMBeijnenJHSchellensJHMOral delivery of taxanesInvest New Drugs200119215516211392449
- PeracchiaMTVauthierCPassiraniCCouvreurPLabarreDComplement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticlesLife Sci19976177497619252249
- LemarchandCGrefRCouvreurPPolysaccharide-decorated nanoparticlesEur J Pharm Biopharm20045832734115296959
- Bravo-OsunaISchmitzTBernkop-SchnürchAVauthierCPonchelGElaboration and characterization of thiolated chitosan-coated acrylic nanoparticlesInt J Pharm200631617017516580797
- ChauvierreCLabarreDCouvreurPVauthierCNovel polysaccharide-decorated poly(isobutyl cianoacrylate) nanoparticlesPharm Res2003201786179314661923
- ChauvierreCLabarreDCouvreurPVauthierCRadical polymerization of alkylcyanoacrylates initiated by the redox system dextrancerium (IV) under acidic aqueous conditionsMacromolecules20033660186027
- HassanEEGalloJMA simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strengthPharm Res199074914951694990
- RoldoMHornofMCalicetiPBernkop-SchnürchAMucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluationEur J Pharm Biopharm200457111512114729087
- LeitnerVMGuggiDKraulandAHBernkop-SchnürchANasal delivery of human growth hormone: in vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery systemJ Control Release2004100879515491813
- Bernkop-SchnürchAKastCEGuggiDPermeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systemsJ Control Release20039395103
- Bravo-OsunaITeutonicoDArpiccoSVauthierCPonchelGCharacterization of chitosan thiolation and application to thiol quantification onto nanoparticle surfaceInt J Pharm20073401217318117606340
- CuiFQianFYinCPreparation and characterization of mucoadhesive polymer-coated nanoparticlesInt J Pharm200631615416116567070
- HuangMKhorELimLYUptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylationPharm Res200421234435615032318
- KafedjiiskiKFögerFWerleMBernkop-SchnürchrchASynthesis and in vitro evaluation of a novel chitosan–glutathione conjugatePharm Res20052291480148816132360
- GuggiDBernkop-SchnürchAImproved paracellular uptake by the combination of different types of permeation enhancersInt J Pharm200528814115015607266
- Bernkop-SchnürchASchwarzVSteiningerSPolymers with thiol groups: a new generation of mucoadhesive polymersPharm Res19991687688110397608
- KastCEBernkop-SchnürchAThiolated polymersthiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugatesBiomaterials2001222345235211511031
- Cheon LeeSKimCChan KwonIChungHYoung JeongSPolymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly([var epsilon]-caprolactone) copolymer as a carrier for paclitaxelJ Control Rel2003893437446
- BarrWHRiegelmanSIntestinal drug absorption and metabolism. I. Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorptionJ Pharm Sci19705921541635411337
- Bravo-OsunaIPonchelGVauthierCTuning of shell and core characteristics of chitosan-decorated acrylic nanoparticlesEur J Pharm Sci200730214315417157487
- ChenM-CWongH-SLinK-JThe characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparinBiomaterials200930346629663719767097
- VilaASanchezAJanesKLow molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in miceEur J Pharm Biopharm200457112313114729088
- LinYHChenCTLiangHFNovel nanoparticles for oral insulin delivery via the paracellular pathwayNanotechnology20071810111
- JanesKAAlonsoMJDepolymerized chitosan nanoparticles for protein delivery: preparation and characterizationJ Appli Polym Sci2003881227692776
- MaoSShuaiXUngerFSimonMBiDKisselTThe depolymerization of chitosan: effects on physicochemical and biological propertiesInt J Pharm2004281124554
- Bravo-OsunaIPonchelGVauthierCTuning of shell and core characteristics of chitosan-decorated acrylic nanoparticlesEur J Pharm Sci20073014315417157487
- PassiraniCBarrattGDevissaguetJ-PLabarreDInteractions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement systemLife Sci19986287757859489513
- FengSSWinaKYEffects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugsBiomaterials2005262713272215585275
- FlorenceATNanoparticle uptake by the oral route: fulfilling its potential?Drug Discov Today Technol2005217581
- NorrisDASinkoPJEffect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucinJ Appl Polym Sci19976314811492
- AkhlaghiSPSaremiSOstadSNDinarvandRAtyabiFDiscriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell linesNanomedicine20106568969720172052
- EsmaeiliFDinarvandRGhahremaniMHOstadSNEsmailyHAtyabiFCellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticlesAnticancer Drugs201021435219809300
- ZhaoJKimJEReedELiQQMolecular mechanism of antitumor activity of taxanes in lung cancerInt J Oncol20052724725615942666